Ochiai K - Search Results

1

Cytokine gene expression signature in ovarian clear cell carcinoma.

Yanaihara N, Anglesio MS, Ochiai K, Hirata Y, Saito M, Nagata C, Iida Y, Takakura S, Yamada K, Tanaka T, Okamoto A. Yanaihara N, et al. Among authors: ochiai k. Int J Oncol. 2012 Sep;41(3):1094-100. doi: 10.3892/ijo.2012.1533. Epub 2012 Jun 26. Int J Oncol. 2012. PMID: 22751940

2

[Treatment overview of ovarian cancer].

Yanaihara N, Ochiai K. Yanaihara N, et al. Among authors: ochiai k. Nihon Rinsho. 2012 Jun;70 Suppl 4:557-9. Nihon Rinsho. 2012. PMID: 23156309 Japanese. No abstract available.

3

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.

Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, Ishii N, Yanaihara N, Yamada K, Takikawa O, Kawaguchi R, Isonishi S, Tanaka T, Urashima M. Okamoto A, et al. Among authors: ochiai k. Clin Cancer Res. 2005 Aug 15;11(16):6030-9. doi: 10.1158/1078-0432.CCR-04-2671. Clin Cancer Res. 2005. PMID: 16115948

4

Nonpuerperal inversion of the uterus associated with endometrial cancer: a case report.

Ueda K, Okamoto A, Yamada K, Saito M, Takakura S, Tanaka T, Ochiai K. Ueda K, et al. Among authors: ochiai k. Int J Clin Oncol. 2006 Apr;11(2):153-5. doi: 10.1007/s10147-005-0544-3. Int J Clin Oncol. 2006. PMID: 16622752

5

Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma.

Takakura S, Saito M, Ueda K, Motegi M, Takao M, Yamada K, Okamoto A, Niimi S, Sasaki H, Tanaka T, Ochiai K. Takakura S, et al. Among authors: ochiai k. Int Surg. 2007 Jul-Aug;92(4):202-8. Int Surg. 2007. PMID: 18050828

6

Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.

Okamoto S, Okamoto A, Nikaido T, Saito M, Takao M, Yanaihara N, Takakura S, Ochiai K, Tanaka T. Okamoto S, et al. Among authors: ochiai k. Oncol Rep. 2009 May;21(5):1209-14. doi: 10.3892/or_00000343. Oncol Rep. 2009. PMID: 19360296

7

Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study.

Takakura S, Takano M, Takahashi F, Saito T, Aoki D, Inaba N, Noda K, Sugiyama T, Ochiai K; Japanese Gynecologic Oncology Group. Takakura S, et al. Among authors: ochiai k. Int J Gynecol Cancer. 2010 Feb;20(2):240-7. doi: 10.1111/igc.0b013e3181cafb47. Int J Gynecol Cancer. 2010. PMID: 20169667 Clinical Trial.

8

[Molecular genetic of gynecological cancer].

Yanaihara N, Okamoto A, Yanagida S, Ochiai K, Tanaka T. Yanaihara N, et al. Among authors: ochiai k. Nihon Rinsho. 2010 Aug;68 Suppl 8:489-93. Nihon Rinsho. 2010. PMID: 20976924 Review. Japanese. No abstract available.

9

Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3.

Ueda K, Yamada K, Kiyokawa T, Iida Y, Nagata C, Hamada T, Saito M, Aoki K, Yanaihara N, Takakura S, Okamoto A, Ochiai K, Ohkawa K, Tanaka T. Ueda K, et al. Among authors: ochiai k. J Obstet Gynaecol Res. 2012 Sep;38(9):1211-9. doi: 10.1111/j.1447-0756.2012.01853.x. Epub 2012 May 8. J Obstet Gynaecol Res. 2012. PMID: 22563698

10

Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy.

Kunito S, Takakura S, Nagata C, Saito M, Yanaihara N, Yamada K, Okamoto A, Sasaki H, Ochiai K, Tanaka T. Kunito S, et al. Among authors: ochiai k. J Obstet Gynaecol Res. 2012 Dec;38(12):1367-75. doi: 10.1111/j.1447-0756.2012.01884.x. Epub 2012 May 28. J Obstet Gynaecol Res. 2012. PMID: 22639843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

868 results

Search Page